Firms

Sectoral Asset Management

Montreal, Quebec, Canada · Geneva, Switzerland · Hong Kong

sectoral.comadviserinfo.sec.gov

Sectoral Asset Management Inc. is an employee-owned Canadian healthcare investment manager founded in Montreal in October 2000 by Jérôme Pfund and Michael Sjöström, with offices in Montreal, Geneva and Hong Kong. SEC adviser CRD110345 identifies the legal Canadian manager; the Geneva office is a branch of the Montreal company, rather than an unrelated Swiss venture firm. Sectoral manages public healthcare and biotechnology equity strategies as well as private investments through the New Emerging Medical Opportunities (NEMO) late-stage venture funds and Fonds Medtech Ventures (FMV) for early-stage Canadian medical technology. Its neuroscience and deep-technology portfolio includes Route 92 Medical’s stroke-intervention devices, Noctrix Health’s wearable neuromodulation and Phagenesis’ neurostimulation treatment for neurogenic dysphagia. Current published team and separately qualified industry/advisory affiliates are linked with authentic source portraits; memorial entries are not represented as current employees. NEMO V reached a final close above USD150M in September 2022, NEMO IV closed at USD96M, and NEMO VI had a USD100M first close on February 2, 2026; a USD200M objective is a target, not a final close. Public strategy composites, certificates, client assets and AUM are distinct from closed venture-fund capital. Sectoral is a verified participant in Route 92 Medical’s actual USD50M growth financing announced April 7, 2026, with the company owner maintaining the single existing round. FMV had a minimum CAD41.5 million first close announced May 30, 2023, with capital intended for early-stage Canadian medtech. Its first-close minimum is not represented as a verified exact final fundraising total.

Founded

2000

Type

Venture capital

Team

Operations and support

Adil EssakhiSystems Administrator

Amanda AdlerAdvisory Network member (published affiliation; current activity unverified)

Angus C. RussellAdvisory Network member (published affiliation; current activity unverified)

Antoine BlondinRegional Director – Europe

Arek AlszkoDirector of Information Technology

Brett GoodinDirector Australia

Catherine ProtopoulosSenior Accountant

Christopher KentPrincipal

David VeinoIndustry Partner (published affiliation)

Frank MaAdvisory Network member (published affiliation; current activity unverified)

François BeaubienPartner

Frederic PfundFormer Marketing Assistant (In memoriam)

Gabriel DouvillePrincipal

Gauthier SanzSenior Analyst

Howard RibackDirector, Venture Capital

James XieCompliance Manager

Jeanne MagramIndustry Partner (published affiliation)

Jivka AngelovaHead of Operations

John ReganDirector of Finance

Jonathan MaOperations Analyst

Justin GélinasSenior Manager, Risk & Operations

Jérôme PfundCEO

Kevin VosAssociate

Magdalena LeszczynieckaAdvisory Network member (published affiliation; current activity unverified)

Marc-André MarcottePartner & Head of Venture Capital

Marco CianfloneHead of Public Equities & Senior Portfolio Manager

Mark CaiFinancial Analyst

Michael SjöströmCo-founder & Partner

Michel AguetAdvisory Network member (published affiliation; current activity unverified)

Nizar ZeinIndustry Partner (published affiliation)

Nury CortezOffice Administrator

Oern StugeIndustry Partner (published affiliation)

Philippe DemersIndustry Partner (published affiliation)

Stefan LarsonVenture Partner

Thierry AbribatIndustry Partner (published affiliation)

Thierry MartinSenior Advisor- GCC

Toby MaFinancial Analyst

Uday KumarIndustry Partner (published affiliation)

Vannesa WongBusiness Development Manager

Vincent DuhamelDirector Canada

Vishar Subramanian VasudevanAdvisory Network member (published affiliation; current activity unverified)

Wayne MahPortfolio Manager

William N. StarlingAdvisory Network member (published affiliation; current activity unverified)

Winnie PunDirector Hong Kong

Yingdong ZhangRegional Director - Asia

SHOW MORE

Co-investing

U.S. Venture Partners

• Route 92 Medical$50M · 2026-04-07
• Iantrek, Inc.$42M · 2025-08-20

Visionary Ventures

• Iantrek, Inc.$42M · 2025-08-20
• Iantrek, Inc.$23M · 2022-08-30

aMoon

• Iantrek, Inc.$42M · 2025-08-20

British Patient Capital

• Phagenesis$42M · 2024-03-04

Casper de Clercq

• Route 92 Medical$50M · 2026-04-07

SHOW MORE

Investments

$42M2024-03-04	Phagenesis	EQT Life Sciences, Sectoral Asset Management, British Patient Capital, Northern Gritstone
$50M2026-04-07	Route 92 Medical	Novo Holdings, Casper de Clercq, InnovaHealth Partners, Norwest Venture Partners, U.S. Venture Partners, The Vertical Group, Sectoral Asset Management
$42M2025-08-20	Iantrek, Inc.	U.S. Venture Partners, Civilization Ventures, aMoon, Visionary Ventures, Sectoral Asset Management
$23M2022-08-30	Iantrek, Inc.	Visionary Ventures, Sectoral Asset Management
$—Unknown date	Atea Pharmaceuticals	Sectoral Asset Management
$—Unknown date	Effector Therapeutics	Sectoral Asset Management
$—Unknown date	Iantrek, Inc.	Sectoral Asset Management
$—Unknown date	Apellis Pharmaceuticals	Sectoral Asset Management
$—Unknown date	Kolltan Pharmaceuticals	Sectoral Asset Management

SHOW MORE